George F. Widhopf - Concepedia

Author

George F. Widhopf

Also Known As

G F Widhopf, G F Widhopf II, G Widhopf, G. F. WIDHOPF, G. F. Widhopf, G. WIDHOPF, G.F. Widhopf, GEORGE F. WIDHOPF, George F Widhopf, George F. Widhopf

152

Publications

5.3K

Citations

H-Index

108

Concepts

All Affiliations

University of California San Diego The Aerospace Corporation Moores Cancer Center The Ohio State University Dana-Farber Cancer Institute

About

George F. Widhopf is an author at University of California San Diego specializing in engineering, fluid mechanics, and numerical simulation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	12	17	1.5K
2	Medicine	8	8	1.9K
3	Natural Sciences	3	3	97
4	Applied Physics	3	3	104
5	Health Sciences	1	1	182

George F. Widhopf

Publications

5.1K

Citations

H-Index

Page 1

	Year	Citations
Relation of Gene Expression Phenotype to Immunoglobulin Mutation Genotype in B Cell Chronic Lymphocytic Leukemia Andreas Rosenwald, Ash A. Alizadeh, George F. Widhopf, The Journal of Experimental Medicine Rearranged ImmunoglobulinEngineeringMixed-phenotype Acute LeukemiaGeneticsImmunology	2001	1.1K
Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia Liguang Chen, George F. Widhopf, Lang Huynh, Blood	2002	507
Antisera induced by infusions of autologous Ad-CD154-leukemia B cells identify ROR1 as an oncofetal antigen and receptor for Wnt5a Tetsuya Fukuda, Liguang Chen, Tomoyuki Endo, Proceedings of the National Academy of Sciences	2008	310
Chronic lymphocytic leukemia B cells of more than 1% of patients express virtually identical immunoglobulins George F. Widhopf, Laura Z. Rassenti, Traci L. Toy, Blood	2004	246
Targeting ROR1 Inhibits Epithelial–Mesenchymal Transition and Metastasis Bing Cui, Suping Zhang, Liguang Chen, Cancer Research	2013	195
Wnt5a induces ROR1/ROR2 heterooligomerization to enhance leukemia chemotaxis and proliferation Jian Yu, Liguang Chen, Bing Cui, Journal of Clinical Investigation Cancer ResearchReceptor TyrosineSignaling PathwayCell RegulationLeukemia Chemotaxis	2015	183
Ovarian cancer stem cells express ROR1, which can be targeted for anti–cancer-stem-cell therapy Suping Zhang, Bing Cui, Grace Liu, Proceedings of the National Academy of Sciences Stem Cell BiologyCancer BiologyTumor BiologyOvarian CancerOvarian Cancers	2014	182
Phase I Trial: Cirmtuzumab Inhibits ROR1 Signaling and Stemness Signatures in Patients with Chronic Lymphocytic Leukemia Michael Y. Choi, George F. Widhopf, Emanuela M. Ghia, Cell stem cell Hematological MalignancyStemness SignaturesLymphoid NeoplasiaChronic Lymphocytic LeukemiaMedicine	2018	180
Alternative and Classical NF-κB Signaling Retain Autoreactive B Cells in the Splenic Marginal Zone and Result in Lupus-like Disease Thomas Enzler, Giuseppina Bonizzi, Gregg J. Silverman, Immunity InflammationLupus-like DiseaseAutoimmune DiseaseAutoantibody ProductionAdaptive Immune System	2006	165
High-level ROR1 associates with accelerated disease progression in chronic lymphocytic leukemia Bing Cui, Emanuela M. Ghia, Liguang Chen, Blood	2016	143

Page 1